The Journal of Organic Chemistry
Article
the general procedure. Purification by column chromatography over
silica (isohexane/ethyl acetate 2/1) afforded the title compound as a
yellow oil (140 mg, 0.34 mmol, 67%). Rf = 0.19. 1H NMR (300 MHz,
CDCl3): δ = 7.74−7.65 (m, 4H), 7.53−7.39 (m, 6H), 7.21−7.11 (m,
3H), 6.99 (dd, J = 7.3, 2.0 Hz, 2H), 5.43−5.30 (m, 2H), 4.58 (s, 2H),
3.83 (d, J = 4.4 Hz, 2H), 3.56 (s, 3H), 1.61 (d, J = 4.6 Hz, 3H) ppm.
13C NMR (75 MHz, CDCl3): δ = 168.4, 166.0, 138.6, 131.9, 131.1,
129.9, 129.4, 128.3, 128.2, 127.7, 127.5, 126.6, 59.4, 53.5, 50.5, 17.8
ppm. MS (EI): m/z = 200 (16), 186 (100), 91 (26). HRMS-(ESIpos):
[M + Na]+ calcd for C27H27NO3SNa 468.1603, found 468.1608. IR
(neat): ν = 3061, 3026, 2944, 2916, 2854, 2239, 1961, 1739, 1645,
1588, 1574, 1494, 1475, 1441, 1431, 1407, 1359, 1279, 1233, 1179,
1131, 1098, 1075, 1023, 999, 970, 950, 910,728, 686 cm−1.
General Procedure for Cyclopropanation. A solution of
sulfonium ylide (0.2 mmol) and Echavaren’s catalyst (0.01 mmol)
was dissolved in dry toluene. The resulting mixture was heated to 100
°C until TLC showed complete consumption of the ylide. The
resulting solution was cooled to room temperature and directly
purified by column chromatography affording the desired cyclo-
propanation product.
ASSOCIATED CONTENT
* Supporting Information
Crystallographic data, details of mechanistic experiments,
documentation of theoretical calculations, NMR spectra, and
chromatograms. The Supporting Information is available free of
■
S
AUTHOR INFORMATION
Corresponding Authors
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
Generous support of this research by the Deutsche
Forschungsgemeinschaft (DFG, Grants MA 4861/4-1 and/4-
2) and the University of Vienna is acknowledged. Mrs. U.
Methyl 2-Oxo-4-pentyl-3-oxabicyclo[3.1.0]hexane-1-carboxylate
(4j). The compound was prepared according to the general procedure
using ylide 1j. Purification by column chromatography over silica (n-
pentane/ethyl acetate 9/1 to 1/1) afforded the title compound as a
colorless oil (45 mg, 199 μmol, 99%, dr = 95:5). Rf = 0.68 (n-pentane/
Rosentreter (MPI Mulheim) and Mrs. E. Macoratti (U.
̈
Vienna) are acknowledged for analytical determination. Parts
of this research were carried out at the Max-Planck-Institut fur
Kohlenforschung, which we gratefully acknowledge. L.F.V.
̈
1
ethyl acetate 1/1). H NMR (300 MHz, CDCl3): δ = 4.28 (t, J = 6.2
Hz, 1H), 3.80 (s, 3H), 2.50 (dd, J = 8.1, 5.5 Hz, 1H), 2.02 (dd, J = 8.1,
4.7 Hz, 1H), 1.74−1.62 (m, 1H), 1.48−1.23 (m, 8H), 0.87 (t, J = 6.9
Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.2, 167.5, 79.0,
53.0, 36.0, 32.7, 31.5, 29.8, 23.8, 22.5, 21.1, 14.0. MS (EI): m/z = 155
(100), 127 (23), 95 (12) ppm. HRMS (ESIpos): calcd for
C12H18O4Na: 249.1097, found 249.1096. IR (neat): ν (cm−1) =
2955, 2932, 2860, 2318, 1776, 1728, 1439, 1377, 1349, 1308, 1264,
1231, 1202, 1174, 1125, 1095, 1083, 1045, 991, 945, 912, 790, 771,
729 cm−1. The enantiomeric excess was determined by chiral GC using
a IVADEX 1/PS 086 G 548 (25 m) column: temp 80 1N 180 10/MIN
220; 0.4 bar H2. Minor enantiomer tR = 72.28 min.Major enantiomer:
tR = 73.32 min.
Methyl 4-Butyl-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carboxylate
(4l). The compound was prepared according to the general procedure
using ylide 1l. Purification by column chromatography over silica (n-
pentane/ethyl acetate 5/1 to 1/1) afforded the title compound as a
colorless oil (27 mg, 0.13 mmol, 82%, dr = 95:5). Rf = 0.68 (n-
pentane/ethyl acetate 1/1). 1H NMR (300 MHz, CDCl3): δ 4.29 (t, J
= 6.2 Hz, 1H), 3.82 (s, 3H), 2.54−2.45 (m, 1H), 2.04 (dd, J = 8.1, 4.7
Hz, 1H), 1.71 (ddd, J = 13.2, 7.9, 4.9 Hz, 2H), 1.49−1.22 (m, 5H),
0.92 (t, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 170.2,
167.6, 79.1, 53.1, 35.8, 32.7, 29.9, 26.3, 22.5, 21.2, 14.0 ppm. MS (EI):
m/z = 155 (100), 127 (32), 123 (10), 95 (17), 59 (10). HRMS
(ESIpos): calcd for C11H16O4Na 212.24, found 212.24. IR (neat): ν
(cm−1) = 2956, 2933, 2862, 1777, 1728, 1439, 1376, 1349, 1309, 1265,
1202, 1174, 1094, 1047, 979, 937, 911, 788, 767, 734 cm−1.
Methyl 3-Benzyl-6-methyl-2-oxo-3-azabicyclo[3.1.0]hexane-1-
carboxylate (11). The compound was prepared according to the
general procedure using ylide 10. Purification by column chromatog-
raphy over silica (isohexane/ethyl acetate 2/1 to 1/1) afforded the title
compound as a colorless oil (45 mg, 199 μmol, 99%, dr = 4.5:1). Rf =
0.34 (isohexane/ethyl acetate 1/1). 1H NMR (300 MHz, CDCl3): δ =
7.31−7.07 (m, 5H), 4.43 (d, J = 14.6 Hz) and 4.39 (d, J = 14.6 Hz)
(1H), 4.18 (d, J = 14.6 Hz) and 4.16 (d, J = 14.6 Hz) (1H), 3.75 (s)
and 3.72 (s) (1H), 3.38 (dd, J = 11.0, 6.4 Hz) and 3.32 (dd, J = 10.2,
5.8 Hz) (1H), 3.02 (d, J = 10.2 Hz) and 2.90 (d, J = 11.0 Hz) (1H),
2.27−2.15 (m) and 2.05 (t, J = 5.4 Hz, 1H), 1.39−1.27 (m, 1H), 1.19
(d, J = 6.1 Hz) and 0.88 (d, J = 6.4 Hz) (1H) ppm. 13C NMR (75
MHz, CDCl3): δ = 170.2, 169.7, 168.0, 167.3, 136.5, 136.0, 128.8,
128.8, 128.3, 127.9, 127.8, 52.6, 52.5, 46.7, 46.6, 43.1, 37.2, 36.9, 29.6,
27.7, 26.6, 25.6, 12.2, 7.1 ppm. MS (EI): m/z = 259 (64), 227 (67),
199 (60), 118 (30), 109 (12), 95 (19), 91 (100), 65 (20). HRMS
(ESIpos): calcd for C15H17O3NNa 282.1106, found 282.1099.
acknowledges Fundaca
̧
o para a Cien
̂
cia e Tecnologia, Projecto
̃
Estrateg
́
ico - PEst-OE/QUI/UI0100/2013.
REFERENCES
■
(1) For selected reviews on gold(I) catalysis, see: (a) Dyker, G.
Angew. Chem., Int. Ed. 2000, 39, 4237. (b) Hoffmann-Roder, A.;
Krause, N. Org. Biomol. Chem. 2005, 3, 387. (c) Hashmi, A. S. K.;
Hutchings, G. Angew. Chem., Int. Ed. 2006, 45, 7896. (d) Furstner, A.;
Davies, P. W. Angew. Chem., Int. Ed. 2007, 46, 3410. (e) Jimenez-
Nunez, E.; Echavarren, A. M. Chem. Commun. 2007, 333. (f) Hashmi,
A. S. K. Chem. Rev. 2007, 107, 3180. (g) Li, Z.; Brouwer, C.; He, C.
Chem. Rev. 2008, 108, 3239. (h) Arcadi, A. Chem. Rev. 2008, 108,
3266. (i) Shen, H. C. Tetrahedron 2008, 64, 3885. (j) Shen, H. C.
̈
̈
Tetrahedron 2008, 64, 7847. (k) Furstner, A. Chem. Soc. Rev. 2009, 38,
̈
3208. (l) Shapiro, N.; Toste, F. D. Synlett 2010, 675. (m) Bandini, M.
Chem. Soc. Rev. 2011, 40, 1358.
(2) (a) Chiarucci, M.; Bandini, M. Beilstein J. Org. Chem. 2013, 9,
2586. (b) Marion, N.; Nolan, S. P. Chem. Soc. Rev. 2008, 37, 1776.
(3) For selected examples, see: (a) Yang, C.; He, C.-G. J. Am. Chem.
Soc. 2005, 127, 6966. (b) LaLonde, R. L.; Brenzovich, W. E., Jr.;
Benitez, D.; Tkatchouk, E.; Kelley, K.; Goddard, W. A., III; Toste, F.
D. Chem. Sci. 2010, 1, 226. (c) Brouwer, C.; He, C. Angew. Chem., Int.
Ed. 2006, 45, 1744. (d) Bender, C.-F.; Widenhoefer, R. A. Chem.
Commun. 2006, 45, 4143. (e) Han, X.; Widenhoefer, R. A. Angew.
Chem., Int. Ed. 2006, 45, 1747. (f) Liu, X.-Y.; Li, C. H.; Che, C. M. Org.
Lett. 2006, 8, 2707. (g) Li, H.; Song, F.; Widenhoefer, R. A. Adv. Synth.
Catal. 2011, 353, 955. (h) Kanno, O.; Kuriyama, W.; Wang, Z. J.;
Toste, F. D. Angew. Chem., Int. Ed. 2011, 50, 9919.
(4) For examples, see: (a) Zhou, C.-Y.; Che, C.-M. J. Am. Chem. Soc.
2007, 129, 5828. (b) Wang, M.-Z.; Wong, M.-K.; Che, C.-M. Chem.
Eur. J. 2008, 14, 8353. (c) Xiao, Y.-P.; Liu, X.-Y.; Che, C.-M. Angew.
Chem., Int. Ed. 2011, 50, 4937. (d) Xiao, Y.-P.; Liu, X.-Y.; Che, C.-M.
Beilstein J. Org. Chem. 2011, 7, 1100. (e) Rao, W.; Susanti, D.; Chan, P.
W. H. J. Am. Chem. Soc. 2011, 133, 15248. (f) Huang, X.; Klimczyk, S.;
Veiros, L. F.; Maulide, N. Chem. Sci. 2013, 4, 1105.
(5) Huang, X.; Peng, B.; Luparia, M.; Gomes, L.; Veiros, L. F.;
Maulide, N. Angew. Chem., Int. Ed. 2012, 51, 8886.
(6) (a) Nieto-Oberhuber, C.; Lop
́ ́
ez, S.; Munoz, M. P.; Cardenas, D.
̃
J.; Bunuel, E.; Nevado, C.; Echavarren, A. M. Angew. Chem., Int. Ed.
̃
́ ́ ́
2005, 44, 6146. (b) Perez-Galan, P.; Delpont, N.; Herrero-Gomez, E.;
Maseras, F.; Echavarren, A. M. Chem.Eur. J. 2010, 16, 5234.
(c) Lop
́
ez-Carrillo, V.; Echavarren, A. M. J. Am. Chem. Soc. 2010, 132,
J
J. Org. Chem. XXXX, XXX, XXX−XXX